Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
======================================================================================================================================================================================================================

* Alexandros Papachristofilou
* Madeleine M. Hipp
* Ute Klinkhardt
* Martin Früh
* Martin Sebastian
* Christian Weiss
* Miklos Pless
* Richard Cathomas
* Wolfgang Hilbe
* Georg Pall
* Thomas Wehler
* Jürgen Alt
* Helge Bischoff
* Michael Geißler
* Frank Griesinger
* Karl-Josef Kallen
* Mariola Fotin-Mleczek
* Andreas Schröder
* Birgit Scheel
* Anke Muth
* Tobias Seibel
* Claudia Stosnach
* Fatma Doener
* Henoch S. Hong
* Sven D. Koch
* Ulrike Gnad-Vogt
* Alfred Zippelius